{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:46:18Z","timestamp":1791251178017,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1124\/mol.107.043299","type":"journal-article","created":{"date-parts":[[2008,1,3]],"date-time":"2008-01-03T01:57:39Z","timestamp":1199325459000},"page":"1203-1212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene"],"prefix":"10.1016","volume":"73","author":[{"given":"Gennady","family":"Cherednichenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris W.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Cabrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Michaelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Samso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac N.","family":"Pessah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.043299_REF1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.bpa.2003.09.012","article-title":"Malignant hyperthermia","volume":"17","author":"Ali","year":"2003","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1124\/mol.107.043299_REF2","doi-asserted-by":"crossref","first-page":"14237","DOI":"10.1074\/jbc.M208372200","article-title":"Diketopyridylryanodine has three concentration-dependent effects on the cardiac calcium-release channel\/ryanodine receptor","volume":"278","author":"Bidasee","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1439-0442.1995.tb00420.x","article-title":"The reduction of skeletal muscle lesions after experimental stress in stress-susceptible pigs protected with dantrolene","volume":"42","author":"Bjurstr\u00f6m","year":"1995","journal-title":"Zentralbl Veterinar Med A"},{"key":"10.1124\/mol.107.043299_REF4","doi-asserted-by":"crossref","first-page":"C1156","DOI":"10.1152\/ajpcell.00397.2006","article-title":"Ca2+ sparks and T-tubule reorganization in dedifferentiating adult mouse skeletal muscle fibers","volume":"292","author":"Brown","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.107.043299_REF5","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1074\/jbc.272.11.7360","article-title":"Dyspedic mouse skeletal muscle expresses major elements of the triadic junction but lacks detectable ryanodine receptor protein and function","volume":"272","author":"Buck","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF6","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1085\/jgp.50.9.2177","article-title":"Effects of external calcium deprivation on single muscle fibers","volume":"50","author":"Caputo","year":"1967","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.107.043299_REF7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1096\/fj.05-4497fje","article-title":"Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse","volume":"20","author":"Chelu","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/mol.107.043299_REF8","doi-asserted-by":"crossref","first-page":"15793","DOI":"10.1073\/pnas.0403485101","article-title":"Conformational activation of calcium entry by depolarization of skeletal myotubes","volume":"101","author":"Cherednichenko","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.043299_REF9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpainsymman.2004.05.002","article-title":"Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review","volume":"28","author":"Chou","year":"2004","journal-title":"J Pain Sympt Manag"},{"key":"10.1124\/mol.107.043299_REF10","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/S0021-9258(18)45858-9","article-title":"Receptor-activated Ca2+ influx. Two independently regulated mechanisms of influx stimulation coexist in neurosecretory PC12 cells","volume":"267","author":"Clementi","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF11","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00415-005-0006-x","article-title":"Diagnosis and management of acute movement disorders","volume":"252","author":"Dressler","year":"2005","journal-title":"J Neurol"},{"key":"10.1124\/mol.107.043299_REF12","doi-asserted-by":"crossref","first-page":"33341","DOI":"10.1074\/jbc.274.47.33341","article-title":"A postulated role of the near amino-terminal domain of the ryanodine receptor in the regulation of the sarcoplasmic reticulum Ca2+ channel","volume":"274","author":"El-Hayek","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF13","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/S0006-3495(00)76492-7","article-title":"Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line","volume":"79","author":"Fessenden","year":"2000","journal-title":"Biophys J"},{"key":"10.1124\/mol.107.043299_REF14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","article-title":"Dantrolene dose response in awake man: implications for management of malignant hyperthermia","volume":"59","author":"Flewellen","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.107.043299_REF15","doi-asserted-by":"crossref","first-page":"26965","DOI":"10.1074\/jbc.272.43.26965","article-title":"Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors","volume":"272","author":"Fruen","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF16","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1073\/pnas.070056497","article-title":"Involvement of multiple intracellular release channels in calcium sparks of skeletal muscle","volume":"97","author":"Gonz\u00e1lez","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/mol.107.043299_REF17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00626225","article-title":"The effect of repetitive stimulation at low frequencies upon the electrical and mechanical activity of single muscle fibres","volume":"334","author":"Grabowski","year":"1972","journal-title":"Pflugers Arch"},{"key":"10.1124\/mol.107.043299_REF18","series-title":"Anesthesia","article-title":"Malignant Hyperthermia","author":"Gronert","year":"2004"},{"key":"10.1124\/mol.107.043299_REF19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3565(25)25650-6","article-title":"The effect of ryanodine on the contractile strength of mammalian cardiac (atrial) muscle","volume":"127","author":"Hillyard","year":"1959","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043299_REF20","doi-asserted-by":"crossref","first-page":"36994","DOI":"10.1074\/jbc.M506441200","article-title":"Ryanodine receptor type 1 (RyR1) mutations C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion","volume":"280","author":"Hurne","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0006-3495(88)83178-3","article-title":"Simultaneous recording of calcium transients in skeletal muscle using high- and low-affinity calcium indicators","volume":"53","author":"Klein","year":"1988","journal-title":"Biophys J"},{"key":"10.1124\/mol.107.043299_REF22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.2527\/1994.7282008x","article-title":"Effect of dantrolene treatment on muscle metabolism and meat quality of anesthetized pigs of different halothane genotypes","volume":"72","author":"Klont","year":"1994","journal-title":"J Anim Sci"},{"key":"10.1124\/mol.107.043299_REF23","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1074\/jbc.M408375200","article-title":"Dantrolene stabilizes domain interactions within the ryanodine receptor","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","article-title":"Dantrolene - a review of its pharmacology, therapeutic use and new developments","volume":"59","author":"Krause","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1124\/mol.107.043299_REF25","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00134-002-1241-6","article-title":"Successful treatment of a complicated case of neuroleptic malignant syndrome","volume":"28","author":"Lappa","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1124\/mol.107.043299_REF26","first-page":"102","article-title":"Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome","volume":"36","author":"L\u00f3pez","year":"1985","journal-title":"Acta Cient Venez"},{"key":"10.1124\/mol.107.043299_REF27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0143-4160(87)90013-3","article-title":"Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine","volume":"8","author":"L\u00f3pez","year":"1987","journal-title":"Cell Calcium"},{"key":"10.1124\/mol.107.043299_REF28","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/00000542-200006000-00040","article-title":"Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+]","volume":"92","author":"L\u00f3pez","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.107.043299_REF29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00000542-199205000-00008","article-title":"Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia","volume":"76","author":"L\u00f3pez","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.107.043299_REF30","first-page":"135","article-title":"Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia","volume":"41","author":"L\u00f3pez","year":"1990","journal-title":"Acta Cient Venez"},{"key":"10.1124\/mol.107.043299_REF31","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2741\/A899","article-title":"Regulation of mammalian ryanodine receptors","volume":"7","author":"Meissner","year":"2002","journal-title":"Front Biosci"},{"key":"10.1124\/mol.107.043299_REF32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1042\/BJ20061040","article-title":"Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia","volume":"402","author":"Murayama","year":"2007","journal-title":"Biochem J"},{"key":"10.1124\/mol.107.043299_REF33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2460\/javma.1991.198.06.989","article-title":"Malignant hyperthermia in dogs","volume":"198","author":"Nelson","year":"1991","journal-title":"J Am Vet Med Assoc"},{"key":"10.1124\/mol.107.043299_REF34","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/jm9805079","article-title":"[3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum","volume":"42","author":"Palnitkar","year":"1999","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.043299_REF35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/bj3260847","article-title":"Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle","volume":"326","author":"Palnitkar","year":"1997","journal-title":"Biochem J"},{"key":"10.1124\/mol.107.043299_REF36","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1074\/jbc.270.31.18465","article-title":"Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum","volume":"270","author":"Parness","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/bi001502s","article-title":"The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling","volume":"40","author":"Paul-Pletzer","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/mol.107.043299_REF38","doi-asserted-by":"crossref","first-page":"34918","DOI":"10.1074\/jbc.M205487200","article-title":"Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor","volume":"277","author":"Paul-Pletzer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.exger.2006.11.003","article-title":"Motor neuron targeting of IGF-1 attenuates age-related external Ca2+-dependent skeletal muscle contraction in senescent mice","volume":"42","author":"Payne","year":"2007","journal-title":"Exp Gerontol"},{"key":"10.1124\/mol.107.043299_REF40","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1016\/S0021-9258(19)84428-9","article-title":"Calciumryanodine receptor complex. Solubilization and partial characterization from skeletal muscle junctional sarcoplasmic reticulum vesicles","volume":"261","author":"Pessah","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0026-895X(25)11068-7","article-title":"Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action","volume":"39","author":"Pessah","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.043299_REF42","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1213\/01.ANE.0000184184.40504.F3","article-title":"Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work?","volume":"101","author":"Podranski","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1124\/mol.107.043299_REF43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-3565(25)11690-X","article-title":"The action of ryanodine on mammalian skeletal muscle in situ","volume":"117","author":"Procita","year":"1956","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043299_REF44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0022-3565(25)12522-6","article-title":"Some pharmacological actions of ryanodine in the mammal","volume":"123","author":"Procita","year":"1958","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043299_REF45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0091-679X(08)60382-9","article-title":"Methods for myoblast transplantation","volume":"52","author":"Rando","year":"1997","journal-title":"Methods Cell Biol"},{"key":"10.1124\/mol.107.043299_REF46","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc5148","article-title":"Managing an effective treatment for neuroleptic malignant syndrome","volume":"11","author":"Reulbach","year":"2007","journal-title":"Crit Care"},{"key":"10.1124\/mol.107.043299_REF47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00000542-200109000-00026","article-title":"Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1)","volume":"95","author":"Roberts","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.107.043299_REF48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1124\/mol.107.043299_REF49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nsmb938","article-title":"Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM","volume":"12","author":"Samso","year":"2005","journal-title":"Nat Struct Molec Biol"},{"key":"10.1124\/mol.107.043299_REF50","first-page":"456","article-title":"The pharmacological management of spasticity","volume":"38","author":"Saulino","year":"2006","journal-title":"J Neurosci Nurs"},{"key":"10.1124\/mol.107.043299_REF51","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1124\/mol.107.043299_REF52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1085\/jgp.118.4.355","article-title":"Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers","volume":"118","author":"Szentesi","year":"2001","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.107.043299_REF53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2005.05.001","article-title":"Pharmacotherapy of spasticity in children with cerebral palsy","volume":"34","author":"Verrotti","year":"2006","journal-title":"Ped Neurol"},{"key":"10.1124\/mol.107.043299_REF54","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/jm00387a022","article-title":"Structural aspects of ryanodine action and selectivity","volume":"30","author":"Waterhouse","year":"1987","journal-title":"J Med Chem"},{"key":"10.1124\/mol.107.043299_REF55","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.1074\/jbc.275.16.11618","article-title":"Postulated role of interdomain interaction within the ryanodine receptor in Ca2+ channel regulation","volume":"275","author":"Yamamoto","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF56","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1006\/bbrc.2002.6569","article-title":"Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor","volume":"291","author":"Yamamoto","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.107.043299_REF57","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/bi015581z","article-title":"Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor","volume":"41","author":"Yamamoto","year":"2002","journal-title":"Biochemistry"},{"key":"10.1124\/mol.107.043299_REF58","doi-asserted-by":"crossref","first-page":"C1591","DOI":"10.1152\/ajpcell.00133.2006","article-title":"Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR","volume":"292","author":"Yang","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.107.043299_REF59","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/00000542-200612000-00016","article-title":"Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse","volume":"105","author":"Yang","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.107.043299_REF60","doi-asserted-by":"crossref","first-page":"25722","DOI":"10.1074\/jbc.M302165200","article-title":"Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling","volume":"278","author":"Yang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/jpet.105.084046","article-title":"Effects of azumolene on Ca2+ sparks in skeletal muscle fibers","volume":"314","author":"Zhang","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.043299_REF62","doi-asserted-by":"crossref","first-page":"13810","DOI":"10.1074\/jbc.M006104200","article-title":"Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity","volume":"276","author":"Zhao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF63","doi-asserted-by":"crossref","first-page":"33477","DOI":"10.1074\/jbc.M602306200","article-title":"Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor","volume":"281","author":"Zhao","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.043299_REF64","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0026-895X(25)09235-1","article-title":"Ryanodine induces persistent inactivation of the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum","volume":"42","author":"Zim\u00e1nyi","year":"1992","journal-title":"Mol Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24048181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24048181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.043299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T23:40:56Z","timestamp":1739490056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24048181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0026895X24048181"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.043299","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.043299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}